Direct-to-consumer genetic testing (DTCGT) from companies such as Ancestry and 23andMe has significantly impacted the dialogue around gamete (sperm and egg) donor conception. In the UK where the anonymity of donors is theoretically protected until a donor-conceived person turns 18, the growing use of DTCGT has prompted the regulator of reproductive technologies, the Human Fertilisation […]
